Literature DB >> 12514661

High triglycerides/low high-density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease.

Jørgen Jeppesen1, Hans Ole Hein, Poul Suadicani, Finn Gyntelberg.   

Abstract

BACKGROUND: High triglycerides (TG)/low high-density lipoprotein cholesterol (HDL-C)(TG > or =1.60 and HDL-C < or =1.18 mmol/L) and ischemic ST-T changes in the resting electrocardiogram (ECG) are both strong risk factors of ischemic heart disease (IHD) in men without clinical cardiovascular diseases. This study tested the hypothesis that men free of clinical IHD with high TG/low HDL-C and resting ischemic ECG changes would have a particularly poor prognosis with respect to IHD.
METHODS: We conducted a cohort study of 2906 men, aged 53 to 74 years, without overt IHD at baseline.
RESULTS: During 8 years, IHD developed in 229 men; 61 cases were fatal. Of the risk factors recorded, ischemic ECG changes and high TG/low HDL-C were the strongest risk factors of IHD. Compared with men without high TG/low HDL-C and without ischemic ECG changes, age-adjusted relative risk of total IHD (95% CI) was 3.5 (1.7-7.2) in men with both high TG/low HDL-C and ischemic ECG changes; the corresponding value for fatal IHD was 11.2 (4.9-25.8). Adjusted for conventional risk factors, the interaction term high TG/low HDL-C x ischemic ECG changes was a significant predictor of IHD death, with a relative risk of 2.6 (1.0-6.9).
CONCLUSIONS: In men free of clinical IHD, ischemic ECG changes were significantly more predictive of fatal IHD in men with high TG/low HDL-C, indicating an adverse synergistic effect of these 2 risk factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514661     DOI: 10.1067/mhj.2003.45

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Plasma adiponectin and insulin resistance in new onset hypertension.

Authors:  Teoman Dogru; Alper Sonmez; Ilker Tasci; M Ilker Yilmaz; Selim Kilic; Taner Ozgurtas; Tayfun Eyileten; M Kemal Erbil; I Hakki Kocar
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  Sonographic fatty liver, overweight and ischemic heart disease.

Authors:  Yu-Cheng Lin; Huey-Ming Lo; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

3.  Insulin resistance and triglyceride/HDLc index are associated with coronary artery disease.

Authors:  Marcello C Bertoluci; Alexandre S Quadros; Rogério Sarmento-Leite; Beatriz D Schaan
Journal:  Diabetol Metab Syndr       Date:  2010-02-03       Impact factor: 3.320

4.  Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine.

Authors:  John W Newcomer; Jonathan M Meyer; Ross A Baker; James M Eudicone; Andrei Pikalov; Estelle Vester-Blokland; Robert D McQuade; David T Crandall; William H Carson; Ronald N Marcus; Gilbert L'italien
Journal:  Schizophr Res       Date:  2008-10-29       Impact factor: 4.939

5.  Postprandial lipemia in pre- and postmenopausal women.

Authors:  Gaffar S Zaman; Sajida Rahman; Jalelur Rahman
Journal:  J Nat Sci Biol Med       Date:  2012-01

6.  Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia.

Authors:  Genovefa D Kolovou; Katherine Anagnostopoulou; Nektarios D Pilatis; Klelia D Salpea; Ioannis S Hoursalas; Ilias Petropoulos; Helen I Bilianou; Dennis V Cokkinos
Journal:  Vasc Health Risk Manag       Date:  2005

Review 7.  Beta-glucans in the treatment of diabetes and associated cardiovascular risks.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Vasc Health Risk Manag       Date:  2008

8.  Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study).

Authors:  Carlos A Aguilar-Salinas; Andréia Assis-Luores-Vale; Benjamín Stockins; Hector Mario Rengifo; José Dondici Filho; Abrahão Afiune Neto; Lísia Marcílio Rabelo; Kerginaldo Paulo Torres; José Egídio Paulo de Oliveira; Carlos Alberto Machado; Eliana Reyes; Victor Saavedra; Fernando Florenzano; Ma Victoria Hernández; Sergio Hernandez Jiménez; Erika Ramírez; Cuauhtémoc Vazquez; Saul Salinas; Ismael Hernández; Octavio Medel; Ricardo Moreno; Paula Lugo; Ricardo Alvarado; Roopa Mehta; Victor Gutierrez; Francisco J Gómez Pérez
Journal:  Cardiovasc Diabetol       Date:  2004-07-23       Impact factor: 9.951

9.  Clinical lipid control success rate before and after percutaneous coronary intervention in iran; a single center study.

Authors:  Seyed Kianoosh Hosseini; Maryam Tahvildari; Mohammad Javad Alemzadeh Ansari; Manouchehr Nakhjavani; Alireza Esteghamati; Masoumeh Lotfi Tokaldany
Journal:  Iran Red Crescent Med J       Date:  2013-06-05       Impact factor: 0.611

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.